DHEA has not been reliably shown to reduce hot flashes. While one small pilot study found a 50% decrease in hot flash scores after four weeks, a larger and more rigorous trial of 60 perimenopausal women taking the same dose for three months found no improvement in hot flash severity or other menopausal symptoms. The evidence is thin and contradictory, which puts DHEA well below standard hormone therapy in terms of proven effectiveness for vasomotor symptoms.
How DHEA Relates to Hormones
DHEA (dehydroepiandrosterone) is a hormone produced mainly by your adrenal glands. Your body uses it as a building block for other hormones, converting it into both testosterone and estradiol through a series of enzymatic steps. In premenopausal women, this conversion pathway supplies roughly 75% of the body’s estrogen. After menopause, when the ovaries stop producing estrogen directly, the main remaining source of estradiol comes from DHEA circulating in the blood being converted into estrogen inside fat tissue.
This is the logic behind DHEA supplementation for menopause symptoms: if your body can turn DHEA into estrogen, then taking extra DHEA might raise estrogen levels enough to ease hot flashes. And DHEA levels do decline naturally with age, dropping significantly by the time most women reach menopause. The theory makes biological sense on paper.
What the Clinical Evidence Shows
The problem is that the theory hasn’t held up well in practice. The most encouraging result comes from a pilot study of just 22 women who took 50 mg of DHEA daily for four weeks. That study reported a 50% reduction in mean hot flash scores and a statistically significant improvement in quality of life related to hot flashes. But pilot studies are small and designed to test whether a larger trial is worth doing, not to prove a treatment works.
A more robust three-month study of 60 perimenopausal women taking the same 50 mg daily dose told a different story. Blood tests confirmed that DHEA was doing what it’s supposed to do biochemically: prohormone and testosterone levels rose, and estradiol levels doubled. Despite those hormonal changes, the researchers reported no improvement in the severity of perimenopausal symptoms, including hot flashes. There was also no benefit for mood, libido, cognition, or general wellbeing.
This disconnect, where hormone levels change but symptoms don’t, suggests that the amount of estrogen produced from oral DHEA may simply not be enough to cross the threshold needed to quiet the brain’s temperature-regulation system, which is what drives hot flashes. Standard hormone therapy delivers estrogen more directly and at more predictable levels, which is why it remains the most effective treatment for moderate to severe hot flashes.
Dosing in Clinical Trials
Most clinical trials have used what’s called a physiologic dose of 25 to 50 mg per day. The recommended supplementation dose for postmenopausal women specifically is 25 mg daily. Some studies have tested much higher amounts, up to 1,600 mg per day, but these pharmacologic doses carry greater risk of side effects without established additional benefit for menopausal symptoms.
In the pilot study that showed some promise, participants took 50 mg once daily and noticed changes within four weeks. But given that the larger trial using the same dose and a longer timeframe showed no benefit, even this dosing regimen doesn’t have strong support.
Side Effects and Risks
Because DHEA converts into both estrogen and testosterone, it can produce androgenic (male-pattern) effects in women. The most common include oily skin, acne, and unwanted facial or body hair growth. These effects are more likely at higher doses but can occur even at the 25 to 50 mg range.
DHEA may also lower HDL cholesterol, the protective “good” cholesterol. Women with high cholesterol or heart disease should be particularly cautious. And because DHEA raises levels of sex hormones, women with a history of hormone-sensitive conditions, including certain breast cancers, face additional risk from supplementation. DHEA is sold as a dietary supplement in the United States, which means it isn’t regulated the same way prescription medications are, and potency can vary between products.
How DHEA Compares to Standard Treatment
Estrogen-based hormone therapy remains the gold standard for treating hot flashes, with large trials consistently showing significant reductions in both frequency and severity. DHEA doesn’t come close to matching that track record. The body’s conversion of DHEA into estrogen is indirect, variable from person to person, and produces unpredictable hormone levels compared to taking estrogen itself.
For women who can’t or prefer not to use hormone therapy, several other options have stronger evidence behind them than DHEA. Certain antidepressants, a newer class of medication that targets the brain’s temperature control center, and some lifestyle modifications all have more consistent data supporting their use. DHEA occupies an uncertain space: biologically plausible, occasionally promising in very small studies, but not backed by the kind of evidence that would make it a confident recommendation for hot flash relief.